Jessica Garcia/LinkedIn
Jul 13, 2026, 18:42
Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
Jessica Garcia, Pediatric Hematologist, Hemostasis and Thrombosis Specialist at UT Southwestern Medical Center, shared a post on LinkedIn:
“Honored to present at International Society on Thrombosis and Haemostasis (ISTH) this year in Paris.
Our poster highlighted thrombin generation patterns in a patient with type 3 VWD with inhibitor on emicizumab prophylaxis, including both in vitro spiking with recombinant FVIIa and in vivo peri‑operative data.
A great discussion on how global assays can capture (and sometimes challenge) what we expect clinically.”
More posts featuring Jessica Garcia on Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients